SCHEMBL16923116

SCHEMBL16923116

c1ccc2c(c1)c1ccccc1n2-c1cc(-n2c3cnccc3c3ncccc32)cc(-n2c3ccccc3c3ccccc32)n1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MKNK1 Q9BUB5 1/20 0.36
MKNK2 Q9HBH9 1/20 0.36
L3MBTL1 Q9Y468 2/20 0.35
KDM4E B2RXH2 1/20 0.35
ATM Q13315 1/20 0.35
CYP1A2 P05177 2/20 0.34
METAP2 P50579 2/20 0.34
CDK4 P11802 2/20 0.34
CDK6 Q00534 2/20 0.34
MAPT P10636 2/20 0.33
MAOA P21397 4/20 0.33
MAOB P27338 4/20 0.33
ACHE P22303 1/20 0.33
PDPK1 O15530 1/20 0.32
TGFBR1 P36897 1/20 0.32
IKBKE Q14164 1/20 0.32
TBK1 Q9UHD2 1/20 0.32
TOP2A P11388 1/20 0.32
ALDH1A1 P00352 1/20 0.32
GSK3B P49841 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17320278 0.89 KDM4E (0.43) MKNK1MKNK2L3MBTL1KDM4EATM
SCHEMBL261898 0.87 MAOA (0.43) L3MBTL1KDM4EATMCYP1A2METAP2
SCHEMBL13811431 0.83 MAOA (0.46) L3MBTL1KDM4EATMCYP1A2METAP2
SCHEMBL13006524 0.83 CCR1 (0.36) MKNK1MKNK2L3MBTL1KDM4ECYP1A2
SCHEMBL21610893 0.81 MAOA (0.43) L3MBTL1KDM4EATMCYP1A2METAP2
SCHEMBL15907063 0.81 KDM4E (0.48) L3MBTL1KDM4EATMMETAP2MAPT
SCHEMBL4561557 0.80 GRM5 (0.33) MKNK1MKNK2L3MBTL1KDM4EATM
SCHEMBL4561482 0.80 GRM5 (0.33) MKNK1MKNK2L3MBTL1KDM4EATM
SCHEMBL12919283 0.79 GRM5 (0.36) L3MBTL1KDM4EATMCYP1A2METAP2
SCHEMBL5021391 0.79 KDM4E (0.50) L3MBTL1KDM4EATMCYP1A2METAP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9917263-B2 Transparent electrode, electronic device, and organic electroluminescent element Konica Minolta, Inc. (JP) 2018-03-13 US disclosed
US-9917263-B2 Transparent electrode, electronic device, and organic electroluminescent element Konica Minolta, Inc. (JP) 2018-03-13 US disclosed
US-9871209-B2 Transparent electrode, electronic device, and organic electroluminescent device Konica Minolta, Inc. (JP) 2018-01-16 US disclosed
US-9871209-B2 Transparent electrode, electronic device, and organic electroluminescent device Konica Minolta, Inc. (JP) 2018-01-16 US disclosed
US-9871220-B2 Transparent electrode, and electronic device Konica Minolta, Inc. (JP) 2018-01-16 US disclosed
US-9871220-B2 Transparent electrode, and electronic device Konica Minolta, Inc. (JP) 2018-01-16 US disclosed
US-20160380227-A1 ORGANIC ELECTROLUMINESCENT ELEMENT Konica Minolta, Inc. (JP) 2016-12-29 US disclosed
US-20150311452-A1 TRANSPARENT ELECTRODE, ELECTRONIC DEVICE, AND ORGANIC ELECTROLUMINESCENT DEVICE Konica Minolta, Inc. (JP) 2015-10-29 US disclosed
US-20150311467-A1 TRANSPARENT ELECTRODE, AND ELECTRONIC DEVICE Konica Minolta, Inc. (JP) 2015-10-29 US disclosed
US-20150311452-A1 TRANSPARENT ELECTRODE, ELECTRONIC DEVICE, AND ORGANIC ELECTROLUMINESCENT DEVICE Konica Minolta, Inc. (JP) 2015-10-29 US disclosed
US-20150311467-A1 TRANSPARENT ELECTRODE, AND ELECTRONIC DEVICE Konica Minolta, Inc. (JP) 2015-10-29 US disclosed
US-20150207080-A1 TRANSPARENT ELECTRODE, ELECTRONIC DEVICE, AND METHOD FOR MANUFACTURING TRANSPARENT ELECTRODE KONICA MINOLTA INC. (JP) 2015-07-23 US disclosed
US-20150207080-A1 TRANSPARENT ELECTRODE, ELECTRONIC DEVICE, AND METHOD FOR MANUFACTURING TRANSPARENT ELECTRODE KONICA MINOLTA INC. (JP) 2015-07-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150311467-A1 TRANSPARENT ELECTRODE, AND ELECTRONIC DEVICE NCL, NPM1, L1CAM MKNK1 1056/4885MKNK2 1286/4885L3MBTL1 3427/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.